New diabetes clinical trial: Gliflozins and Cardiovascular Risk Factors in Type 2 Diabetes (GIOIA)

by ranadeep bhowmik April 17, 2019 0 Comments
Published on: April 17, 2019 at 09:30PM
Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: SGLT-2i;   Drug: DPP-4i
Sponsor:   University of Campania "Luigi Vanvitelli"
Recruiting
http://bit.ly/2V9VtQ4

0 Comments